| Identification | Back Directory | [Name]
5-[(1R)-2-[6-(2,2-difluoro-2-phenyl-ethoxy)hexylamino]-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one: naphthalene-1,5-disulfonic acid (2:1) | [CAS]
1044516-17-7 | [Synonyms]
LAS100977 napadisylate Abediterol napadisylate 5-[(1R)-2-[6-(2,2-difluoro-2-phenyl-ethoxy)hexylamino]-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one: naphthalene-1,5-disulfonic acid (2:1) | [EINECS(EC#)]
811-620-3 | [Molecular Formula]
C35H38F2N2O10S2 | [MOL File]
1044516-17-7.mol | [Molecular Weight]
748.81 |
| Hazard Information | Back Directory | [Uses]
Abediterol napadisylate is an inhaled long-acting β2-adrenoceptor agonist (LABA) and can be used for the research of asthma and chronic obstructive pulmonary disease (COPD)[1]. | [References]
[1] Ramos I, et al. Abediterol (LAS100977), an inhaled long-acting β2-adrenoceptor agonist, has a fast association rate and long residence time at receptor. European Journal of Pharmacology, 2018, 819: 89-97. |
|
|